These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18178782)

  • 21. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral antidiabetic agents for the general practitioner].
    Siegmund T
    MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interview with Prof. Erland Erdmann, Cologne. Oral antidiabetic with protective effect].
    Erdmann E
    MMW Fortschr Med; 2006 Oct; 148(41):51. PubMed ID: 17190266
    [No Abstract]   [Full Text] [Related]  

  • 25. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes.
    McCarren M
    Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic nephropathy.
    Castellino P; Giordano M; Tuttle KR
    Curr Ther Endocrinol Metab; 1997; 6():465-75. PubMed ID: 9174791
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy.
    Rizvi AA; McLaughlin N
    South Med J; 2009 Sep; 102(9):985. PubMed ID: 19668037
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on systemic management of diabetes.
    Masharani U; Rushakoff RJ
    Int Ophthalmol Clin; 2009; 49(2):13-33. PubMed ID: 19349784
    [No Abstract]   [Full Text] [Related]  

  • 29. [New aspects in prevention and therapy of diabetic nephropathy].
    Rheinberger M; Büttner R; Böger CA
    Dtsch Med Wochenschr; 2016 Feb; 141(3):186-9. PubMed ID: 26841180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medical treatment of type 2 diabetes. Recommendations for good practice].
    Diabetes Metab; 2007 Jan; 33(1 Pt 2):1S7-25. PubMed ID: 17499189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Bothe D
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2390; author reply 2390-1. PubMed ID: 23132160
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
    Fogo AB
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vildagliptin in renal impairment.
    Dongre N; Kothny W
    J Nephrol; 2014 Jun; 27(3):349. PubMed ID: 24800907
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients.
    Durán-Nah JJ; Rodríguez-Morales A; Smitheram J; Correa-Medina C
    Rev Invest Clin; 2008; 60(6):451-8. PubMed ID: 19378831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive glucose control in type 2 diabetes.
    Parashar A
    N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837128
    [No Abstract]   [Full Text] [Related]  

  • 36. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current state of diabetes care and a role for nurse practitioners. Introduction.
    Hinnen D
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():6; quiz 22-3. PubMed ID: 19125790
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions].
    Vesti-Nielsen J; Westerlund P; Bygren P
    Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2094-7. PubMed ID: 18751447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.